Postablation syndrome hits RFA liver patients

Article

One-third of patients at the University of Texas Health Science Center in San Antonio who underwent radiofrequency ablation of liver tumors briefly developed symptoms such as fever, delayed pain, malaise, chills, and nausea after the procedure. Clinical reports sporadically mention these symptoms, but none has scrutinized them in detail until now, according to Dr. Gerald Dodd and colleagues at UT (AJR 2005; 185:51-57).

One-third of patients at the University of Texas Health Science Center in San Antonio who underwent radiofrequency ablation of liver tumors briefly developed symptoms such as fever, delayed pain, malaise, chills, and nausea after the procedure. Clinical reports sporadically mention these symptoms, but none has scrutinized them in detail until now, according to Dr. Gerald Dodd and colleagues at UT (AJR 2005; 185:51-57).

Researchers prospectively reviewed delayed symptoms in 39 patients with 89 liver tumor nodules who underwent 50 consecutive RFA sessions. They found the flulike symptoms were directly related to the volume of ablated tissue.

Statistically significant predictors for these symptoms included tumor volumes larger than 50 cm3, ablated tissue volumes larger than 150 cm3, difference between actual tumor volume and volume of tissue ablated larger than 125 cm3, difference between actual tumor volume and volume of tissue ablated larger than 125 cm3, and post-RFA aspartate aminotransferase levels above 350 IU/L.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.